CARTOX Cell Therapy Group Active IEC Therapy Protocol and Patient Reviews - 12/15/2022

RSS

Add to Calendar CARTOX Cell Therapy Group Active IEC Therapy Protocol and Patient Reviews - 12/15/2022 12/15/2022 4:00:00 PM 12/15/2022 5:30:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/course/courseoverview?EID=24731 Description: Immune Effector Cell (IEC) Therapy Toxicity Assessment and Management, also known as CARTOX, including T cells and natural killer cells, which are genetically engineered to express a chimeric antigen receptor (CAR), constitute a powerful new class of therapeutic agents to treat patients with hematologic malignancies.This series is the only essential platform which all providers of IEC therapy part... Virtual false MM/DD/YYYY


Date & Location
Thursday, December 15, 2022, 4:00 PM - 5:30 PM, Virtual

Target Audience
Professions - Nurse - RN, Other, Pharmacist, Physician (MD or DO)

Credits
AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Attendance (1.50 hours)

Overview

Immune Effector Cell (IEC) Therapy Toxicity Assessment and Management, also known as CARTOX, including T cells and natural killer cells, which are genetically engineered to express a chimeric antigen receptor (CAR), constitute a powerful new class of therapeutic agents to treat patients with hematologic malignancies.  

This series is the only essential platform which all providers of IEC therapy participate in to learn the most critical treatment guidelines, regulatory requirements, newest development, issues identified and corrective action plans implemented.



Objective(s): 1 Utilize the current IEC treatment guidelines and, most agreed upon, good practices. 2 Assess patient cases and their outcomes. 3 Identify the development trend of IEC therapy and new modalities emerging for clinical studies. 4 Identify common issues and implement corrective plans.
Location: Virtual
Specialties: Other

Faculty Disclosures:
Elizabeth J Shpall, MD (Nothing to disclose - 11/09/2022)
Download Handout

Download Handout

Objectives
At the conclusion of this activity, learners will be able to:

  1. Utilize the current IEC treatment guidelines and, most agreed upon, good practices.
  2. Assess patient cases and their outcomes.
  3. Identify the development trend of IEC therapy and new modalities emerging for clinical studies.
  4. Identify common issues and implement corrective plans.

Accreditation
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 



Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.